Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amgen (NQ: AMGN )

218.76 -2.00 (-0.91%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 9, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,708,007
Open 219.34
Bid (Size) 218.55 (1)
Ask (Size) 219.36 (2)
Prev. Close 220.76
Today's Range 217.77 - 220.94
52wk Range 211.71 - 296.67
Shares Outstanding N/A
Dividend Yield 3.22%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Is AbbVie or Amgen the Better Bargain Buy Right Now?
These elite drugmakers are both working through a number of headwinds. 
Via The Motley Fool
ASCO 2023 – Claudin 6 Makes A Splash In Ovarian Cancer
This year’s 2023 American Society of Clinical Oncology Annual Meeting (ASCO 2023) provided a surprising amount of clinical data relevant to biopharma investors. 
Via Benzinga

Performance

YTD
-16.39%
-16.39%
1 Month
-6.56%
-6.56%
3 Month
-4.00%
-4.00%
6 Month
-21.49%
-21.49%
1 Year
-9.51%
-9.51%

More News

Read More
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 3% Dividend Yields
Via Benzinga
The 3 Best Long-Term Dividend Stocks to Buy in June
Via InvestorPlace
Dow Stocks Like Microsoft, Apple, Disney, and Verizon Reveal Two Sides of the Market
Via The Motley Fool
Here's How Much $1000 Invested In Amgen 15 Years Ago Would Be Worth Today
Via Benzinga
Amgen Unusual Options Activity For June 01
Via Benzinga
Why AbbVie and Amgen Are Moving Lower Today
Via The Motley Fool
The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree
Via Investor's Business Daily
3 Undervalued Biotech Stocks to Buy Before They Blast Off
Via InvestorPlace
Is Amgen a Good Dividend Stock?
Via The Motley Fool
3 Stocks Worth Buying at 52-Week Lows
Via MarketBeat
Check Out What Whales Are Doing With AMGN
Via Benzinga
Amgen's Debt Overview
Via Benzinga
Here's How Much You Would Have Made Owning Amgen Stock In The Last 15 Years
Via Benzinga
Top-Ranked Dividend Stocks: A Smarter Way To Boost Your Retirement Income
Via Talk Markets
A Challenger to J&J's Top Blockbuster Is on the Way. Here's What You Need to Know.
Via The Motley Fool
3 Dogs of the Dow for High-Yield Investors
Via InvestorPlace
FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
The Important — And Overlooked — Caveat Behind Pfizer's Rival To Novo Nordisk In Diabetes
Via Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Pfizer Stock Jumps After Diabetes Drug Tops Ozempic In Weight Loss
Via Investor's Business Daily
Stock Market Rally Hits 2023 Highs As Big Techs Lead; Tesla, Walmart, On Holding In Focus: Weekly Review
Via Investor's Business Daily
Is Pfizer's Seagen Deal In Jeopardy Amid Antitrust Scrutiny?
Via MarketBeat
Topics Bonds
Exposures Debt Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.